Does AZATHIOPRINE Cause Hepatocellular carcinoma? 28 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Hepatocellular carcinoma have been filed in association with AZATHIOPRINE (AZATHIOPRINE). This represents 0.1% of all adverse event reports for AZATHIOPRINE.
28
Reports of Hepatocellular carcinoma with AZATHIOPRINE
0.1%
of all AZATHIOPRINE reports
4
Deaths
9
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From AZATHIOPRINE?
Of the 28 reports, 4 (14.3%) resulted in death, 9 (32.1%) required hospitalization, and 2 (7.1%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZATHIOPRINE. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does AZATHIOPRINE Cause?
Drug ineffective (8,076)
Off label use (5,358)
Drug intolerance (3,392)
Condition aggravated (2,832)
Rheumatoid arthritis (2,746)
Treatment failure (2,483)
Arthralgia (2,427)
Drug hypersensitivity (2,421)
Nausea (2,178)
Pneumonia (2,157)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which AZATHIOPRINE Alternatives Have Lower Hepatocellular carcinoma Risk?
AZATHIOPRINE vs AZD-1222
AZATHIOPRINE vs AZELAIC ACID
AZATHIOPRINE vs AZELASTINE
AZATHIOPRINE vs AZELASTINE\FLUTICASONE
AZATHIOPRINE vs AZELNIDIPINE